Published in Immunol Rev on April 01, 2000
Diagnosis, pathogenesis, and treatment of autoimmune hepatitis after liver transplantation. Dig Dis Sci (2012) 2.18
Acute and acute severe (fulminant) autoimmune hepatitis. Dig Dis Sci (2012) 2.08
Medullary thymic epithelial cell depletion leads to autoimmune hepatitis. J Clin Invest (2013) 1.57
Autoimmune Hepatitis: Progress from Global Immunosuppression to Personalised Regulatory T Cell Therapy. Can J Gastroenterol Hepatol (2016) 1.39
Novel autoimmune hepatitis-specific autoantigens identified using protein microarray technology. J Proteome Res (2010) 1.15
Aetiopathogenesis of autoimmune hepatitis. World J Gastroenterol (2008) 1.11
Autoimmune hepatitis--approach to diagnosis. MedGenMed (2006) 0.92
Characteristics of autoimmune hepatitis in patients who are not of European Caucasoid ethnic origin. Gut (2002) 0.89
Mechanisms of tissue injury in autoimmune liver diseases. Semin Immunopathol (2014) 0.89
End-organ damage in a mouse model of fulminant liver inflammation requires CD4+ T cell production of IFN-gamma but is independent of Fas. J Immunol (2009) 0.88
Autoimmune hepatitis. Semin Immunopathol (2009) 0.88
Genetic bases of autoimmune hepatitis. Dig Dis Sci (2002) 0.86
Genetic background of autoimmune hepatitis in Japan. J Gastroenterol (2010) 0.84
A 50-year experience with autoimmune hepatitis: and where are we now? J Gastroenterol (2010) 0.83
Relationship between autoimmune hepatitis and HLA-DR4 and DRbeta allelic sequences in the third hypervariable region in Chinese. World J Gastroenterol (2001) 0.83
Epidemiology and treatment of autoimmune hepatitis. Hepat Med (2012) 0.82
An overlap syndrome involving autoimmune hepatitis and systemic lupus erythematosus in childhood. World J Gastroenterol (2007) 0.82
HLA DRB1*13 as a risk factor for type 1 autoimmune hepatitis in North American patients. Dig Dis Sci (2007) 0.82
Structural mimicry between SLA/LP and Rickettsia surface antigens as a driver of autoimmune hepatitis: insights from an in silico study. Theor Biol Med Model (2013) 0.82
The role of Ifng in alterations in liver gene expression in a mouse model of fulminant autoimmune hepatitis. Liver Int (2009) 0.82
Autoimmune hepatitis, one disease with many faces: etiopathogenetic, clinico-laboratory and histological characteristics. World J Gastroenterol (2015) 0.81
Identification of CD4 T-cell epitopes in soluble liver antigen/liver pancreas autoantigen in autoimmune hepatitis. Gastroenterology (2008) 0.81
Meta-analysis: diagnostic accuracy of antinuclear antibodies, smooth muscle antibodies and antibodies to a soluble liver antigen/liver pancreas in autoimmune hepatitis. PLoS One (2014) 0.78
Long-term treatment outcomes for autoimmune hepatitis in Korea. J Korean Med Sci (2009) 0.78
Emerging opportunities for site-specific molecular and cellular interventions in autoimmune hepatitis. Dig Dis Sci (2010) 0.78
Transitioning from Idiopathic to Explainable Autoimmune Hepatitis. Dig Dis Sci (2015) 0.77
Historical reflections on autoimmune hepatitis. World J Gastroenterol (2008) 0.77
A novel "humanized mouse" model for autoimmune hepatitis and the association of gut microbiota with liver inflammation. Hepatology (2015) 0.76
The induction of autoimmune hepatitis in the human leucocyte antigen-DR4 non-obese diabetic mice autoimmune hepatitis mouse model. Clin Exp Immunol (2016) 0.75
Lack of association between the CARD10 rs6000782 polymorphism and type 1 autoimmune hepatitis in a Japanese population. BMC Res Notes (2015) 0.75
"Autoimmune(-Like)" Drug and Herb Induced Liver Injury: New Insights into Molecular Pathogenesis. Int J Mol Sci (2017) 0.75
International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol (1999) 9.11
Long-term outcome of hepatitis C infection after liver transplantation. N Engl J Med (1996) 4.10
The codon 620 tryptophan allele of the lymphoid tyrosine phosphatase (LYP) gene is a major determinant of Graves' disease. J Clin Endocrinol Metab (2004) 2.44
Autoimmune hepatitis in childhood: a 20-year experience. Hepatology (1997) 1.97
Association between HLA and extrahepatic biliary atresia. J Pediatr Gastroenterol Nutr (1993) 1.96
Evidence for an immune response to HLA class I antigens in the vanishing-bileduct syndrome after liver transplantation. Lancet (1987) 1.68
Cytomegalovirus infection and donor/recipient HLA antigens: interdependent co-factors in pathogenesis of vanishing bile-duct syndrome after liver transplantation. Lancet (1988) 1.60
Autoimmune hepatitis/sclerosing cholangitis overlap syndrome in childhood: a 16-year prospective study. Hepatology (2001) 1.59
Cytokine polymorphisms associated with clinical features and treatment outcome in type 1 autoimmune hepatitis. Gastroenterology (1999) 1.56
Hepatitis B virus reinfection after orthotopic liver transplantation. Serological and clinical implications. J Hepatol (1992) 1.46
Hematoxylin substitutes: a survey of mordant dyes tested and consideration of the relation of their structure to performance as nuclear stains. Stain Technol (1976) 1.45
Association between HLA class II genotype and spontaneous clearance of hepatitis C viraemia. J Hepatol (1998) 1.40
De-novo autoimmune hepatitis after liver transplantation. Lancet (1998) 1.30
Cellular and humoral immune reactions against autoantigens and hepatitis C viral antigens in chronic hepatitis C. Gastroenterology (1994) 1.27
Histochemical reactions at tissue arginine sites with alkaline solutions of -naphthoquinone-4-sodium sulfonate and other o-quinones and oxidized o-diphenols. A possible mechanism of the Sakaguchi reaction. J Histochem Cytochem (1971) 1.25
Allelic sequence variation in the HLA class II genes and proteins in patients with autoimmune hepatitis. Hepatology (1994) 1.19
Association of tumor necrosis factor polymorphism with primary sclerosing cholangitis. J Hepatol (1999) 1.18
HLA A1-B8-DR3 and suppressor cell function in first-degree relatives of patients with autoimmune chronic active hepatitis. J Hepatol (1985) 1.17
Associations between alleles of the major histocompatibility complex and type 1 autoimmune hepatitis. Hepatology (1997) 1.16
Allelic basis for HLA-encoded susceptibility to type 1 autoimmune hepatitis. Gastroenterology (1997) 1.15
Apolipoprotein epsilon3 allele is associated with persistent hepatitis C virus infection. Gut (2005) 1.11
Cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphisms and susceptibility to type 1 autoimmune hepatitis. Hepatology (2000) 1.09
HLA DQA, DQB, and DRB genotyping by oligonucleotide analysis: distribution of alleles and haplotypes in British caucasoids. Hum Immunol (1992) 1.03
Schizophrenia and HLA: a review. Schizophr Res (2001) 1.01
Autoantibodies in liver disease. Gastroenterology (2001) 1.01
Frequency and nature of cytokine gene polymorphisms in type 1 autoimmune hepatitis. Hepatology (1999) 1.00
Amino acid substitutions at position 38 of the DR beta polypeptide confer susceptibility to and protection from primary sclerosing cholangitis. Hepatology (1992) 0.99
Failure of budesonide in a pilot study of treatment-dependent autoimmune hepatitis. Gastroenterology (2000) 0.93
The major histocompatibility complex influences the development of chronic liver disease in male children and young adults with cystic fibrosis. J Hepatol (1995) 0.90
HLA-C genes and susceptibility to type 1 autoimmune hepatitis. Hepatology (1997) 0.89
Activation of the complement system in primary sclerosing cholangitis. Gastroenterology (1989) 0.88
Cell-mediated immunity and suppressor-T-cell defects to liver-derived antigens in families of patients with autoimmune chronic active hepatitis. Lancet (1986) 0.88
A functional Fas promoter polymorphism is associated with a severe phenotype in type 1 autoimmune hepatitis characterized by early development of cirrhosis. Tissue Antigens (2007) 0.88
Lymphocyte subset abnormalities, autoantibodies and their relationship with HLA DR types in children with type 1 (insulin-dependent) diabetes and their first degree relatives. Diabetologia (1994) 0.87
Genetic association of the HLA DRB1 gene locus on chromosome 6p21.3 with schizophrenia. Am J Psychiatry (1996) 0.87
Polymorphism in the human complement C4 genes and genetic susceptibility to autoimmune hepatitis. Autoimmunity (1994) 0.86
HLA phenotypes and gene polymorphisms in juvenile liver disease associated with alpha 1-antitrypsin deficiency. Hepatology (1990) 0.86
A major histocompatibility complex class III allotype (C4B 2) associated with primary biliary cirrhosis (PBC). Tissue Antigens (1987) 0.85
Differential staining of collagen types in paraffin sections: a color change in degraded forms. Virchows Arch A Pathol Anat Histol (1980) 0.85
Reduction and azo coupling of quinones. A histochemical study of human cutaneous melanin and adrenochrome. Histochemistry (1977) 0.85
HLA DPB polymorphism in primary sclerosing cholangitis and primary biliary cirrhosis. Hepatology (1995) 0.82
HLA class II genotypes associated with chronic hepatitis C virus infection and response to alpha-interferon treatment in Poland. Liver (2000) 0.82
Influence of IL-6, COL1A1, and VDR gene polymorphisms on bone mineral density in Crohn's disease. Gut (2005) 0.81
Human leukocyte antigen-C genes and susceptibility to primary sclerosing cholangitis. Hepatology (1998) 0.80
TNF gene polymorphisms in primary biliary cirrhosis: a critical appraisal. J Hepatol (1999) 0.79
Nuclear stains with soluble metachrome metal mordant dye lakes. The effect of chemical endgroup blocking reactions and the artificial introduction of acid groups into tissues. Histochemistry (1976) 0.79
Staining mast cells in sublimate-fixed guinea pig tissue. Stain Technol (1973) 0.78
Human leukocyte antigen A1-B8-DR3-DQ2-DPB1*0401 extended haplotype in autoimmune hepatitis. Hepatology (1993) 0.78
Hematoxylin substitutes. A study of phenocyanin TC and the use of afterchrome mordanting in histology. Am J Clin Pathol (1975) 0.77
Autoreactivity to hepatocellular antigens in primary biliary cirrhosis and primary sclerosing cholangitis. J Clin Lab Immunol (1989) 0.77
The relationship between HLA-DR3 and T-cell regulation of immunoglobulin production in primary sclerosing cholangitis. Clin Immunol Immunopathol (1989) 0.77
Chemokine receptor 5 and primary biliary cirrhosis: a two-centre genetic association study. Liver Int (2004) 0.76
The mechanism of the ferric ferricyanide reduction reaction. Histochem J (1974) 0.76
HLA-DRB and DQB typing by a combination of serology, restriction fragment length polymorphism analysis and oligonucleotide probing. Eur J Immunogenet (1991) 0.76
The CC chemokine receptor 5 delta32 mutation is not associated with inflammatory bowel disease (IBD) in NE England. Genes Immun (2001) 0.76
Immunological aspects of liver disease. Gut (1991) 0.75
Do maternal HLA antigens predispose to schizophrenia? Lancet (1993) 0.75
A transmission/disequilibrium study of the DRB1*04 gene locus on chromosome 6p21.3 with schizophrenia. Schizophr Res (1998) 0.75
Hematoxylin substitutes: gallein as a biological stain. Stain Technol (1974) 0.75
Letters: Comment on Solcia and Buffa's "Azo coupling of indole-reactive enterochromaffin cells". J Histochem Cytochem (1974) 0.75
Lower azure B methylene blue ratios in Giemsa type blood and malaria stains. Stain Technol (1978) 0.75
Difficulties in ferrous iron mordant hematoxylin staining and some hematoxylin substitutes. Stain Technol (1971) 0.75
Preparation of eosinates and Giemsa stains of low azure B content from hot acid dichromate oxidized commercial medicinal methylene blue. Stain Technol (1978) 0.75
Autoimmune liver disease. Curr Opin Gastroenterol (2001) 0.75
Letter: Direct carbonyl reaction in mouse mast cells. J Histochem Cytochem (1976) 0.75
Elastin 3. Stains with monoazo dyes. Acta Histochem (1972) 0.75
Indole reactions of mast cells and enterochromaffin cells related to fixations with and without aldehydes. Histochemistry (1978) 0.75
The effect of graded 60 degrees C 1N nitric acid extraction and of deoxyribonuclease digestion on nuclear staining by metachrome mordant dye metal salt mixtures. Histochemistry (1976) 0.75
Zinc chloride methylene blue. I. Biological stain history, physical characteristics and approximation of azure B content of commercial samples. Stain Technol (1979) 0.75
Zinc chloride methylene blue. II. Preparation of Giesma and Wright type low azure B blood stains from dichromate oxidized commercial dye. Stain Technol (1979) 0.75
Primary acid silver nitrate fixation of enterochromaffin and murine mast cells. J Histochem Cytochem (1976) 0.75
Iron gallein in Van Gieson technics, replacing iron hematoxylin. Stain Technol (1973) 0.75
Elastin. IV. Lysinal aldehyde relations, blocking and extraction tests, staining mechanisms. Acta Histochem (1972) 0.75
Borax methylene blue: a spectroscopic and staining study. Stain Technol (1978) 0.75
Fe II uptake of enterochromaffin. Biochemical and histochemical study of the ferrous ion uptake reaction in relation to enterochromaffin cells and mast cells. Acta Histochem (1978) 0.75
T-cell receptor constant beta germline gene polymorphisms and susceptibility to autoimmune hepatitis. Gastroenterology (1994) 0.75
Histochemical azo coupling reactions. A catecholamine in enterochromaffin cells in place of or in addition to 5-hydroxytryptamine. J Histochem Cytochem (1973) 0.75
A consideration of substitutes for alum hematoxylin in routine histologic and cytologic diagnostic procedures. Am J Clin Pathol (1973) 0.75
The wet Giemsa method for quick testing of variants in blood and malaria stains. Stain Technol (1979) 0.75
The pH range of the diazosafranin reaction of rat and other mast cells. J Histochem Cytochem (1973) 0.75
Use of the diazosulfanilic acid, pH 1 azure A sequence on adrenal medulla and the effects of prior oxidation and reduction on the reaction in several species. J Histochem Cytochem (1973) 0.75
Hematoxylin substitutes: fluorone black and methyl fluorone black (9-phenyl- and 9-methyl-2,3,7-trihydroxy-6-fluorone) as metachrome iron alum mordant dyes. Stain Technol (1975) 0.75
The CLARA hematoxylin reaction. Acta Histochem (1974) 0.75
Indulin nigrosin elastin stains. Elastin VI. Stains with alcohol-soluble nigrosins and water soluble indulin and nigrosin and their mechanisms: a lipoprotein component? Acta Histochem (1974) 0.75
Histochemical azo coupling of protein histidine. Brunswik's nitration method. J Histochem Cytochem (1972) 0.75